Tsinghua Tongfang

Tongfang Co., Ltd. is a high-tech company controlled by Tsinghua University. It was established in June 1997 and listed on the Shanghai Stock Exchange with a stock code of 600100. At that time, the stock name was "Tsinghua Tongfang." in 2005, Tsinghua Unicom ranked 23rd in the Top 500 Chinese Electronic Information Enterprises.

 

Tsinghua Tongfang, based on its own core technology, fully integrated its capital operation capabilities and has created four major industries: information technology, energy and environment, application of nuclear electronic technology, and biomedicine.

 

In the information industry, Tsinghua Tongfang is committed to applying technological innovations and product development in the areas of information systems, computer systems, and digital television systems, providing comprehensive solutions and packages for e-government, digital homes, digital cities, digital education, digital media, and other industries. At present, Tsinghua Tongfang has domestic leading strength and market share in computer products, major industry informatization, digital education resources, digital television and other fields.

 

In the energy and environmental industries, Tsinghua Tongfang specialises in energy and environment sector based on core technologies such as flue gas desulfurisation, waste incineration, water treatment, and air conditioning in the fields of artificial environment, energy environment, construction environment, water environment, pollution control engineering, artificial environmental engineering, and significant advantages in large and medium-sized air-conditioning equipment.

In the nuclear electronic technology industry, the series of products with electron accelerators, radiation imaging, automatic control, and digital image processing technologies have reached the international level.

 

In the biopharmaceutical and fine chemical industries, the production of new types of medicines, pharmaceutical intermediates, raw materials, drugs and other products has become a new high-tech biopharmaceutical company.